Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices

被引:59
作者
Siniscalchi, A [1 ]
Rodi, D [1 ]
Beani, L [1 ]
Bianchi, C [1 ]
机构
[1] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy
关键词
nociceptin; ORL1; receptors; 5-HT release; cerebral cortex; rat;
D O I
10.1038/sj.bjp.0702793
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of nociceptin (NC) on S-hydroxytryptamine (5-HT) release was studied in rat cerebral cortex slices preincubated with [H-3]-5-HT and electrically stimulated (3 Hz for 2 min) at the 45th (St(1)) and the 75th (St(2)) min of superfusion. 2 NC (0.1-3 mu M), present in the medium from the 70th min onward, concentration-dependently reduced electrically evoked [H-3]-5-HT efflux (pEC(50) = 6.54, E-max -54%). The inhibition was not antagonized by naloxone (1 mu M) ruling out the involvement of opioid receptors. 3 Phe(1)psi(CH2-NH2)Gly(2)]NC(1-13)NH2, which acts as an opioid-like receptor (ORL1) antagonist at the peripheral level, behaved as a partial agonist in cerebral cortex slices i.e. it inhibited [H-3]-5-HT efflux when added before St(2), however, when present in the medium throughout the whole experiment, [Phe(1)psi(CH2-NH2)Gly(2)]NC(1-13)NH2 prevented the action of NC added at the 70th min. 4 The non-selective ORL1 receptor antagonist, naloxone benzoylhydrazone (3 mu M), in the presence of 10 mu M naloxone, did not modify the St(2)/St(1), ratio but completely abolished the NC effect. 5 These findings demonstrate that NC inhibits 5-HT release from rat cerebral cortex slices via ORL1, receptors, suggesting its involvement in central processes :mediated by 5-HT.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 30 条
[1]   DIFFERENT APPROACHES TO STUDY ACETYLCHOLINE-RELEASE - ENDOGENOUS ACH VERSUS TRITIUM EFFLUX [J].
BEANI, L ;
BIANCHI, C ;
SINISCALCHI, A ;
SIVILOTTI, L ;
TANGANELLI, S ;
VERATTI, E .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 328 (02) :119-126
[2]  
BEANI L, 1978, EUR J PHARMACOL, V48, P89
[3]   Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies [J].
Bigoni, R ;
Giuliani, S ;
Calo, G ;
Rizzi, A ;
Guerrini, R ;
Salvadori, S ;
Regoli, D ;
Maggi, CA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (03) :160-167
[4]  
BRADLEY PB, 1992, SEROTONIN CNS RECEPT, V85, P423
[5]   MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[6]   Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Bianchi, C ;
Regoli, D ;
Salvadori, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3360-3366
[7]   The orphanin FQ system: an emerging target for the management of pain? [J].
Darland, T ;
Grandy, DK .
BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (01) :29-37
[8]  
GOETHERT M, 1991, PRESYNAPTIC REGULATI, P845
[9]   Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide [J].
Guerrini, R ;
Calo, G ;
Rizzi, A ;
Bianchi, C ;
Lazarus, LH ;
Salvadori, S ;
Temussi, PA ;
Regoli, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) :1789-1793
[10]   A new selective antagonist of the nociceptin receptor [J].
Guerrini, R ;
Calo, G ;
Rizzi, A ;
Bigoni, R ;
Bianchi, C ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) :163-165